NASDAQ:SUPN | EBITDA | SUPERNUS PHARMACEUTICALS, INC.

Complete source-backed ebitda history.

Available history
2010-12-31 to 2026-03-31
Data captured

Historical EBITDA

DateEBITDA
2026-03-31$17.8M
2025-12-31$21.08M
2025-03-31$10.13M
2024-12-31$40.25M
2024-03-31$17.6M
2023-12-31$20.68M
2023-03-31$25.78M
2022-12-31$55.18M
2022-03-31$23.33M
2021-12-31$18.81M
2021-03-31$19.81M
2020-12-31$48.52M
2020-03-31$30.74M
2019-12-31$42.45M
2019-03-31$27.11M
2018-12-31$41.55M
2018-03-31$33.1M
2017-12-31$36.01M
2017-03-31$17.53M
2016-12-31$16.97M
2016-03-31$6.87M
2015-12-31$8.15M
2015-03-31$3.64M
2014-12-31-$24.55M
2014-03-31-$13.2M
2013-12-31-$11.14M
2013-03-31-$17.75M
2012-12-31-$12.52M
2012-03-31-$7.65M
2011-12-31-$10.02M
2011-03-31-$8.99M

Annual EBITDA

DateEBITDA
2025-12-31$29.28M
2024-12-31$162.08M
2023-12-31$79.59M
2022-12-31$131.67M
2021-12-31$118.62M
2020-12-31$191.84M
2019-12-31$155.23M
2018-12-31$151.51M
2017-12-31$107.67M
2016-12-31$56.62M
2015-12-31$21.77M
2014-12-31-$4.35M
2013-12-31-$61.18M
2012-12-31-$41.3M
2011-12-31-$36.87M
2010-12-31-$38.94M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.